欧洲对主动脉瘤手术的300年历史贡献
本文回顾欧洲在主动脉瘤手术领域300年的历史贡献,将历史划分为多个时代:18世纪以结扎技术奠定基础原则,19世纪出现早期重建尝试,20世纪突破加速并最终进入腔内时代,欧洲主导了主动脉覆膜支架的首次临床评估与监管批准。
要点
- 18世纪欧洲结扎技术为主动脉瘤手术奠定基础原则。
- 19世纪出现早期主动脉重建尝试。
- 20世纪欧洲主导主动脉覆膜支架首次临床评估与监管批准。
核心结论
- 欧洲的突破性创新逐步将主动脉瘤从不可治愈疾病转变为可治疗疾病,并在腔内时代主导了主动脉覆膜支架的首次临床评估与监管批准。
研究设计与样本
- 本文为历史综述,聚焦欧洲在主动脉瘤手术领域的创新贡献,将300年历史划分为多个 successive 时代进行叙述。
主要发现
- 18世纪以结扎技术为标志,奠定 foundational 原则。
- 19世纪以早期重建尝试为特征。
- 20世纪突破以指数级速度出现, culminating 于腔内时代。
- 欧洲主导了主动脉覆膜支架的首次临床评估与监管批准。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Historically, aortic aneurysms were considered incurable with rupture leading to catastrophic outcomes. But over the centuries, with advances in surgery and in medicine, generally, significant progress has been achieved often by small steps, but occasionally by critical insights and major breakthroughs. Understanding the historical evolution of aortic repair illustrates how incremental innovations transformed a once incurable condition into a treatable disease. A number of important advances took place in America, and many historical reviews have, justly, highlighted these contributions. But this manuscript focuses on the ground-breaking innovations that occurred in Europe and divides the history into successive eras: "The Beginnings; " the 18th century, marked by ligation techniques that laid foundational principles; the 19th century, characterized by early reconstructive attempts; and the 20th century, where breakthroughs were made at an exponential pace, culminating in the endovascular era, in which Europe led the first clinical evaluation and regulatory approval of aortic stent grafts.
引用
- Serena G, Amar G, Pacini D, et al. European Contributions to Aortic Aneurysm Surgery: A 300-Year Historical Perspective. Ann Vasc Surg. 2026. PMID: 42660349. doi:10.1016/j.avsg.2026.08.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。